Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors

Journal of Investigative Dermatology

Volumn 125, Issue 2, 2005, Pages 207-212

  Arbiser, Jack L ^a   Li, Xing Cong ^b   Hossain, Chowdhury Fiaz ^b   Nagle, Dale G ^b   Smith, David M ^c,d   Miller, Paul ^a   Govindarajan, Baskaran ^a   DiCarlo, Josh ^a   Landis Piwowar, Kristin R ^c,d   Dou, Q Ping ^c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Natural product; Psoriasis; Topical

Indexed keywords

3,4 DICAFFEOYLQUINIC ACID; 5 CAFFEOYLQUINIC ACID; CINNAMIC ACID DERIVATIVE; EPIGALLOCATECHIN GALLATE; ISOCHLOROGENIC ACID; NATURAL PRODUCT; PROTEASOME INHIBITOR; RAS PROTEIN; UNCLASSIFIED DRUG; CHLOROGENIC ACID; ESTER; PLANT EXTRACT; PROTEASOME;

ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ILEX PARAGUARIENSIS; INFLAMMATORY DISEASE; LEUKEMIA CELL LINE; MODEL; PRIORITY JOURNAL; PSORIASIS; STRUCTURE ACTIVITY RELATION; CELL CYCLE G2 PHASE; CELL DIVISION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE;

CELL DIVISION; CELL LINE, TRANSFORMED; CHLOROGENIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CINNAMATES; ENDOTHELIAL CELLS; ESTERS; G2 PHASE; HUMANS; ILEX PARAGUARIENSIS; JURKAT CELLS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLANT EXTRACTS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 24344495354     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23809.x     Document Type: Article

References (25)

1. Anghileri LJ, Thouvenot P: Natural polyphenols-iron interaction: Its biological importance. Biol Trace Elem Res 73:251-258, 2000
2. Arbiser JL: Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: Evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Semin Cancer Biol 14:81-91, 2004
3. Arbiser JL, Klauber N, Rohan R, et al: Curcumin is an in vivo inhibitor of angiogenesis [in process citation]. Mol Med 4:376-383, 1998
4. Arbiser JL, Moses MA, Fernandez CA, et al: Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 94:861-866, 1997
5. Arbiser JL, Panigrathy D, Klauber N, Rupnick M, Flynn E, Udagawa T, D'Amato RJ: The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. J Am Acad Dermatol 40:925-929, 1999
6. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H: Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44:425-432, 2001
7. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98:10350-10355, 2001
8. Hausen BM, Evers P, Stuwe HT, Konig WA, Wollenweber E: Propolis allergy (lv)-studies with further sensitizers from propolis and constituents common to propolis, polar buds and balsam of Peru. Contact Dermatitis 26:34-44, 1992
9. Hershko A, Ciechanover A, Varshavsky A: The ubiquitin system. Nature Med 6:1073-1081, 2000
10. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH: Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841-5847, 1994
11. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51:813-819, 1991
12. Jana NR, Dikshit P, Goswami A, Nukina N: Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279:11680-11685, 2004
13. Klafter R, Arbiser JL: Regulation of angiogenesis and tumorigenesis by signal transduction cascades: Lessons from benign and malignant endothelial tumors [in process citation]. J Investig Dermatol Symp Proc 5:79-82, 2000
14. LaMontagne KR Jr, Moses MA, Wiederschain D, et al: Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells [in process citation]. Am J Pathol 157:1937-1945, 2000
15. Lebwohl M: Innovations in the treatment of psoriasis. J Am Acad Dermatol 51:S40-S41, 2004
16. Nam S, Smith DM, Dou QP: Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276:13322-13330, 2001
17. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664-1675, 2004
18. Rao CV, Rivenson A, Simi B, Reddy BS: Chemoprevention of colon cancer by dietary curcumin. Ann N Y Acad Sci 768:201-204, 1995
19. Ren S, Smith MJ, Louro ID, et al: The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma [in process citation]. Oncogene 19:1419-1427, 2000
20. Richardson P, Barlogie B, Berenson J, et al: A phase Il multicenter study of the proteasome inhibitor bortezomib (VELCADE (TM), formerly PS-341) in multiple myeloma patients (pts) with relapsed/refractory disease. Blood 100:104A, 2002
21. Singletary K, MacDonald C, Iovinelli M, Fisher C, Wallig M: Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 19:1039-1043, 1998
22. Stern RS: Psoriasis. Lancet 350:349-353, 1997
23. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK: Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9:305-312, 1998
24. Wrone-Smith T, Nickoloff BJ: Dermal injection of immunocytes induces psoriasis [see comments]. J. Clin Invest 98:1878-1887, 1996
25. Zollner TM, Podda M, Pien C, Elliott PJ, Kaufmann R, Boehncke WH: Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest 109:671-679, 2002